As COVID-19 pandemic has passed a year, the guidelines for drug use are being updated a lot.

As the evidence was accumulated, the differences in the guidelines for use by each country decreased, and detailed recommendations for practical use were derived with recommendations for use and refraining from various cases even with the same drug.

Based on the latest academic research, the KSID (The Korean Society of Infectious Diseases) also presented a guideline for drug treatment for COVID-19 infection on the 31st. Based on this, guidelines for drug use and changes in each case were summarized.

Remdesivir, approved in Korea in July, has detailed use cases for each patient's condit